Pill bottle-themed Lucite tombstone marking the acquisition of a royalty interest in worldwide sales of Xenpozyme. Xenpozyme has been developed and approved as a treatment for acid sphingomyelinase deficiency (ASMD). (22AKL627)
Pill bottle-themed Lucite tombstone marking the acquisition of a royalty interest in worldwide sales of Xenpozyme. Xenpozyme has been developed and approved as a treatment for acid sphingomyelinase deficiency (ASMD). (22AKL627)
Crystal deal toy, incorporating a 3D etching of a DNA strand, commemorating the merger of biotech companies Atrin Pharmaceuticals and Aprea Therapeutics. (22ALJ234)
Crystal financial tombstone recognizing the acquisition of Pathology Consultants. The life sciences company is based in Greenville, South Carolina. (23AZH099)
Crystal deal toy, incorporating the Nasdaq Tower, commemorating an acquisition by urban-gro, a cannabis facility operator. (23ALJ018)
Custom Lucite deal toy recognizing the acquisition of LSL Healthcare. Based in Chicago, LSL manufactures medical devices, hospital supplies, and surgical procedure kits. (23AZH022)
Crystal financial tombstone recognizing an offering y RA Medical Systems. The California-based company is developing a laser system to treat vascular diseases. (23AJH049)
Heart-themed crystal deal toy, incorporating a desktop computer, celebrating an investment in IronRod Health. The Arizona-based company is a provider of a remote patient health monitoring system, and specializes in devices and software addressing cardiac issues. (22AKL583)
Lucite deal toy celebrating a development and commercialization agreement between Click Therapeutics and Boehringer Ingelheim. The collaboration centers on a prescription digital therapeutic for schizophrenia. (22AKL597)
Crystal deal toy celebrating a strategic investment in Plano, Texas-based PSN Group. PSN is a system of ambulatory surgical centers (ASCs) and surgical hospitals. (22AKL495)
